Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Clasificación en acciones
#3676
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Precio por acción
$3.62
Capitalización bursátil
$4.58B
Cambio (1 día)
-0.16%
Cambio (1 año)
-53.12%
País
CN
Comercio Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Categoría
Healthcare
Margen Operativo de Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Margen Operativo al October 2026 TTM: -22.69%
Según los informes financieros más recientes y el precio de las acciones de Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., el margen operativo actual (TTM) es -22.69%. Al final de 2023, el margen operativo era 25.43%.
Historial de Margen Operativo de Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. desde 2013 hasta 2026
Margen Operativo al final de cada año
| Año | Margen Operativo | Cambiar |
|---|---|---|
| 2026 (TTM) | -22.69% | -642.82% |
| 2024 | 4.18% | -83.56% |
| 2023 | 25.43% | -49.17% |
| 2022 | 50.03% | 23.56% |
| 2021 | 40.49% | 22.96% |
| 2020 | 32.93% | 78.58% |
| 2019 | 18.44% | -37.32% |
| 2018 | 29.42% | 56.32% |
| 2017 | 18.82% | 20.87% |
| 2016 | 15.57% | -13.02% |
| 2015 | 17.90% | -7.40% |
| 2014 | 19.33% | 0.26% |
| 2013 | 19.28% | 0.00% |
Margen Operativo de empresas similares o competidoras
| Empresa | Margen Operativo | Diferencia de Margen Operativo | País |
|---|---|---|---|
| 38.59% | -101.70% |
US
|
|
| -149.01% | -93.43% |
US
|
|
| 25.57% | -101.13% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -101.27% |
NL
|
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.